Inflammasome Activation in Myeloid Malignancies—Friend or Foe?

por Andina, Nicola, Bonadies, Nicolas, Allam, Ramanjaneyulu
Publicado 2022

Human molecular genetics sheds light on the physiological significance of ribonuclease inhibitor (RNH1)

por Sarangdhar, Mayuresh Anant, Andina, Nicola, Allam, Ramanjaneyulu
Publicado 2023

Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature

por Buetler, Vanessa Alexandra, Agbariah, Nada, Schild, Deborah Pia, Liechti, Fabian D., Wieland, Anna, Andina, Nicola, Hammann, Felix, Kremer Hovinga, Johanna A.
Publicado 2022

The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial

por Keller, Peter, von Känel, Roland, Hincapié, Cesar A., da Costa, Bruno R., Jüni, Peter, Erlanger, Tobias E., Andina, Nicola, Niederhauser, Christoph, Lämmle, Bernhard, Fontana, Stefano
Publicado 2020

LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity

por Bombaci, Giuseppe, Sarangdhar, Mayuresh Anant, Andina, Nicola, Tardivel, Aubry, Yu, Eric Chi-Wang, Mackie, Gillian M, Pugh, Matthew, Ozan, Vedat Burak, Banz, Yara, Spinetti, Thibaud, Hirzel, Cedric, Youd, Esther, Schefold, Joerg C, Taylor, Graham, Gazdhar, Amiq, Bonadies, Nicolas, Angelillo-Scherrer, Anne, Schneider, Pascal, Maslowski, Kendle M, Allam, Ramanjaneyulu
Publicado 2022